Elanco Animal Health (ELAN) Net Cash Flow (2017 - 2026)

Elanco Animal Health (ELAN) has 10 years of Net Cash Flow data on file, last reported at -$112.0 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow fell 1020.0% year-over-year to -$112.0 million; the trailing twelve-month figure through Mar 2026 stood at -$96.0 million (down 151.89% YoY), and the FY2025 full-year result was $6.0 million, down 97.1% from the prior year.
• Net Cash Flow retreated to -$112.0 million in Q1 2026, from $26.0 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $179.0 million in Q2 2022 to a low of -$291.0 million in Q1 2022.
• A 5-year average of -$9.2 million and a median of $5.0 million in 2023 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow surged 1220.0% in 2024 and slumped 1020.0% in 2026, its largest moves.
• Tracing ELAN's Net Cash Flow over 5 years: stood at -$147.0 million in 2022, then jumped by 88.44% to -$17.0 million in 2023, then surged by 423.53% to $55.0 million in 2024, then sank by 52.73% to $26.0 million in 2025, then tumbled by 530.77% to -$112.0 million in 2026.
• Business Quant data shows ELAN's Net Cash Flow at -$112.0 million in Q1 2026, $26.0 million in Q4 2025, and -$35.0 million in Q3 2025.